A detailed history of Eam Investors, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 174,760 shares of NRIX stock, worth $3.49 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
174,760
Previous 174,077 0.39%
Holding current value
$3.49 Million
Previous $3.63 Million 8.01%
% of portfolio
0.68%
Previous 0.65%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.93 - $25.69 $12,929 - $17,546
683 Added 0.39%
174,760 $3.92 Million
Q2 2024

Aug 12, 2024

BUY
$12.02 - $21.3 $2.09 Million - $3.71 Million
174,077 New
174,077 $3.63 Million
Q4 2020

Feb 11, 2021

SELL
$22.85 - $48.44 $804,548 - $1.71 Million
-35,210 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$16.05 - $34.91 $565,120 - $1.23 Million
35,210 New
35,210 $1.23 Million

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $942M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.